Beschreibung
Future research directions for probiotic-fermented herbal therapeutics in metabolic disease. Knowledge gaps, proposed clinical trial designs, and translational challenges are mapped to guide upcoming investigations.
Figure 24
DiagramSource Paper
Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.Cite This Figure
![Figure 24: Future research directions for probiotic-fermented herbal therapeutics in metabolic disease. Knowledge gaps, proposed clinical trial designs, and translational challenges are mapped to guide upcoming investigations.]() > Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)
<figure> <img src="" alt="Future research directions for probiotic-fermented herbal therapeutics in metabolic disease. Knowledge gaps, proposed clinical trial designs, and translational challenges are mapped to guide upcoming investigations." /> <figcaption>Figure 24. Future research directions for probiotic-fermented herbal therapeutics in metabolic disease. Knowledge gaps, proposed clinical trial designs, and translational challenges are mapped to guide upcoming investigations.<br> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption> </figure>